Hospital-related morbidity in people notified with hepatitis C: A population-based record linkage study in New South Wales, Australia

Journal of Hepatology

Volumn 53, Issue 1, 2010, Pages 43-49

  Gidding, Heather F ^a   Amin, Janaki ^a   Dore, Gregory J ^a   Ward, Kate ^b   Law, Matthew G ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b New South Wales Government   (Australia)

Author keywords

Epidemiology; Hepatitis C; Hospitalization; Morbidity; Record linkage

Indexed keywords

ALCOHOL; ILLICIT DRUG;

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ARTICLE; AUSTRALIA; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; KIDNEY FAILURE; LIFESTYLE MODIFICATION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; NONALCOHOLIC FATTY LIVER; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; STANDARDIZED INCIDENCE RATIO; AGED; ALCOHOLISM; COHORT ANALYSIS; LIVER DISEASES; MIDDLE AGED; RENAL INSUFFICIENCY; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HEPATITIS C; HOSPITALIZATION; HUMANS; KIDNEY FAILURE; LIVER DISEASES; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; MORBIDITY; NEW SOUTH WALES; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT; RENAL INSUFFICIENCY;

EID: 77953548316     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.01.036     Document Type: Article

References (30)

1. Amin J., Dore G.J., O'Connell D.L., Bartlett M., Tracey E., Kaldor J.M., et al. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol 45 (2006) 197-203
2. Amin J., Law M.G., Bartlett M., Kaldor J.M., and Dore G.J. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 368 (2006) 938-945
3. Duberg A.-S., Nordstrom M., Torner A., Reichard O., Strauss R., Janzon R., et al. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology 41 (2005) 652-659
4. Duberg A.-S., Torner A., Davidsdottir L., Aleman S., Blaxhult A., Svensson A., et al. Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study. J Viral Hepat 15 (2008) 538-550
5. McDonald S.A., Hutchinson S.J., Bird S.M., Mills P.R., Dillon J., Bloor M., et al. A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland. Stat Methods Med Res 18 (2009) 271-283
6. McDonald S.A., Hutchinson S.J., Bird S.M., Robertson C., Mills P.R., Dillon J.F., et al. A record-linkage study of the development of hepatocellular carcinoma in persons with hepatitis C infection in Scotland. Br J Cancer 99 (2008) 805-810
7. EASL International Consensus Conference on Hepatitis C. Paris, 26-28, February 1999, Consensus Statement. European Association for the Study of the Liver. J Hepatol 1999;30:956-61.
8. Gidding H.F., Topp L., Middleton M., Robinson K., Hellard M., McCaughan G., et al. The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006. J Gastroenterol Hepatol 24 (2009) 1648-1654
9. Grant W.C., Jhaveri R.R., McHutchison J.G., Schulman K.A., and Kauf T.L. Trends in health care resource use for hepatitis C virus infection in the United States. Hepatology 42 (2005) 1406-1413
10. Myers R.P., Liu M., and Shaheen A.A. The burden of hepatitis C virus infection is growing: a Canadian population-based study of hospitalizations from 1994 to 2004. Can J Gastroenterol 22 (2008) 381-387
11. Thomson S.J., Westlake S., Rahman T.M., Cowan M.L., Majeed A., Maxwell J.D., et al. Chronic liver disease - an increasing problem: a study of hospital admission and mortality rates in England, 1979-2005, with particular reference to alcoholic liver disease. Alcohol Alcohol 43 (2008) 416-422
12. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 340 (1999) 1228-1233
13. Rosenberg D.M., Cook S.F., and Lanza L.L. Health care, treatment patterns and cost of services for patients infected with chronic hepatitis C virus in a large insured New England population. J Viral Hepat 7 (2000) 361-367
14. Steinke D.T., Weston T.L., Morris A.D., MacDonald T.M., and Dillon J.F. Epidemiology and economic burden of viral hepatitis: an observational population based study. Gut 50 (2002) 100-105
15. The Centre for Health Record Linkage [cited 2009 28/9/2009]. Available from: www.cherel.org.au.
16. ChoiceMaker Technologies Inc., New York, NY 10010, USA.
17. Kirkwood B.R., and Sterne J.A.C. Essential medical statistics. 2nd ed. (2003), Blackwell Science Ltd., Malden, MA
18. Stukel T.A., Glynn R.J., Fisher E.S., Sharp S.M., Lu-Yao G., and Wennberg J.E. Standardized rates of recurrent outcomes. Stat Med 13 (1994) 1781-1791
19. Degenhardt L., Kinner S.A., Roxburgh A., Black E., Bruno R., Fetherston J., et al. Drug use and risk among regular injecting drug users in Australia: does age make a difference?. Drug Alcohol Rev 27 (2008) 357-360
20. Day C., Topp L., Rouen D., Darke S., Hall W., and Dolan K. Decreased heroin availability in Sydney in early 2001. Addiction 98 (2003) 93-95
21. Degenhardt L., Day C., Dietze P., Pointer S., Conroy E., Collins L., et al. Effects of a sustained heroin shortage in three Australian States. Addiction 100 (2005) 908-920
22. Razali K., Thein H., Bell J., Cooper-Stanbury M., Dolan K., Dore G.J., et al. Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend 91 (2007) 228-235
23. Poynard T., Bedossa P., and Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349 (1997) 825-832
24. Milner K.L., Chisholm D., and George J. The many faces of hepatitis C: liver disease and type 2 diabetes. Hepatology 50 (2009) 668-670
25. Lecube A., Hernandez C., Genesca J., Esteban J.I., Jardi R., and Simo R. High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury. Diabetes Care 27 (2004) 1171-1175
26. Meyers C.M., Seeff L.B., Stehman-Breen C.O., and Hoofnagle J.H. Hepatitis C and renal disease: an update. Am J Kidney Dis 42 (2003) 631-657
27. Tsui J.I., Vittinghoff E., Shlipak M.G., and O'Hare A.M. Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 17 (2006) 1168-1174
28. Amin J., Law M.G., and Dore G.J. Mortality in patients with hepatitis B or hepatitis C. Lancet 368 (2006) 1767
29. Volzke H., Schwahn C., Wolff B., Mentel R., Robinson D.M., Kleine V., et al. Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis 174 (2004) 99-103
30. National Centre in HIV Epidemiology and Clinical Research. Australian NSP survey national data report, 2004-2008. Sydney: National Centre in HIV Epidemiology and Clinical Research, The University of NSW; 2008.